Original Articles

Effect of Amniotic Membrane Combined with Ciprofloxacin in Curing the Primary Stages of Pseudomonal Keratitis


Background:  Keratitis caused by Pseudomonas  aeruginosa  is often resulted in  severe  corneal  ulcers  and  perforation,  which  leads  to  losses  of  vision. Human amniotic membrane (HAM) forms the inner wall of the membranous sac which surrounds and protects the embryo during gestation. The purpose of this  study  was  to  evaluate  the  effectiveness  of  the  amniotic  membrane's healing in rabbits with pseudomonas keratitis.Methods:  In total 14 rabbits divided in 2 groups of: 1 as Control  and 2 as experimental  amniotic  membrane  combined  with  ciprofloxacin.  A 0.05  ml suspension   of  Pseudomonas   aeruginosa   ATCC  27853  was  injected  into rabbit’s corneal stroma, with no interference in control group. In the second group, the amniotic membrane in pieces of 1.5 × 1.5 cm transplanted  to the entire corneal surface by eight interrupted 10.0 nylon sutures. In the first day ciprofloxacin  drop was injected  to the second  group  every 30 minutes  and through second to seventh days every 2 hours. The results of perforation  in cornea and the amount of infiltration were registered.Results:  The  results  showed  that  amniotic  membrane  transplantation (AMT)  +  ciprofloxacin  group  had  0%  perforation  and  the  control  group 85.6%. Average infiltrations were 5 mm in AMT + ciprofloxacin groups and 23.75 mm in control.Conclusion: The use of amniotic membrane with ciprofloxacin was effective in   prevention   of   cornea   perforation   and   controlling   the   process   of pseudomonal  keratitis remission.  The improvement  of inflammation  rapidly happened in ciprofloxacin + AMT group. 

Van Herendael BJ, Oberti C, Brosens I.Microanatomy of the human amniotic membranes. A light microscopic, transmission, and scanning electron microscopic study. Am J Obstet Gynecol 1978; 131 (8): 872-80.

Prabhasawat P, Tesavibul N, Komolsuradej W.Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol 2001; 85 (12):1455-63.

Shin KS, Chung IY, Seo SW. The effect of amniotic membrane transplantation for corneal ulcer and ocular surface diseases. J Korean Ophthalmol Soc 2003; 44 (6): 1305-10.

Anderson DF, Prabhasawat P, Alfonso E, et al.Amniotic membrane transplantation after the primary surgical management of band keratopathy. Cornea 2001; 20 (4): 354-61.

Espana EM, Crueterich M, Sandoval H, et al.Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg 2003; 29 (2): 279-84.

Tang GG, Ahn HB, Park WC. The clinical effects of dye-amniotic membrane transplantation on bullous keratopathy. J Korean Ophthalmol Soc 2003; 44 (8): 1741-7.

Choi YS, Kim JY, Wee WR, et al. Effect of application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratectomy. Cornea 1998; 17(4): 389-95.

Woo HM, Kim HS, Kweon OK, et al. Effects of amniotic membrane on epithelial wound healing and stromal remodeling after excimer laser keratectomy in rabbit cornea. Br J Ophthalmol 2001; 85 (3): 345-9.

Paridaens D, Beekhuis H, van Den Bosch W, et al. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol 2001; 85 (6): 658-61.

Espana EM, Prabhasawat P, Grueterich M, et al.Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol 2002; 86 (6):640-5.

Ti SE, Tseng SC. Management of primary and recurrent pterygium using amniotic membrane transplantation. Curr Opin Ophthalmol 2002; 13 (4): 204-12.

Shimazaki J, Kosaka K, Shimmura S, et al.Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology 2003; 110 (1): 119-24.

Tseng SC, Prabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1997;124 (6): 765-74.

Jain S, Rastogi A. Evaluation of the outcome of amniotic membrane transplantation for ocular surface reconstruction in symblepharon. Eye 2004; 18 (12): 1251-7.

Tamhane A, Vajpayee RB, Biswas NR, et al.Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. Ophthalmology 2005; 112 (11): 1963-9.

Gomes JA, dos Santos MS, Cunha MC, et al.Amniotic membrane transplantation for partial and total limbal stem cell deficiency secondary to chemical burn. Ophthalmology 2003; 110 (3):466-73.

Tseng SC, Prabhasawat P, Barton K, et al.Amniotic membrane transplantation with or without limbal allograft for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998; 116 (4): 431-41.

Uçakhan OO, Köklü G, Firat E. Nonpreserved human amniotic membrane transplantation in acute and chronic chemical eye injuries. Cornea 2002; 21 (2): 169-72.

Nubile M, Carpineto P, Lanzini M, et al.Multilayer amniotic membrane transplantation for bacterial keratitis with corneal perforation after hyperopic photorefractive keratectomy: case report and literature review. J Cataract Refract Surg 2007; 33 (9): 1636-40.

Gicquel JJ, Bejjani RA, Ellies P, et al. Amniotic membrane transplantation in severe bacterial keratitis. Cornea 2007; 26 (1): 27-33.

Kim JS, Kim JC, Hahn TW, et al. Amniotic membrane transplantation in infectious corneal ulcer. Cornea 2001; 20 (7): 720-6.

Solomon A, Meller D, Prabhasawat P, et al.Amniotic membrane grafts for non traumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology 2002; 109 (4): 694-703.

Ma DH, Wang SF, Su WY, et al. Amniotic membrane graft for the management of scleral melting and corneal perforation in recalcitrant infectious scleral and corneoscleral ulcers.Cornea 2002; 21 (3): 275-283.

Hosseini H, Nejabat M, Mehryar M, et al.Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis. Clin Exp Ophthalmol 2007; 35 (8):745-8.

Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997; 123 (3):303-12.

Dua HS, Gomes JAP, King AJ, et al. The amniotic membrane in ophthalmology. Surv Ophthalmol 2004; 49 (1): 51-77.

Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995; 14 (5): 473-84.

Meller D, Pires RT, Mack RJ, et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 2000; 107 (5):980-9.

Jeoung JW, Yoon YM, Lee JL, et al. The effect of amniotic membrane transplantation on the treatment of necrotizing scleritis after pterygium excision. J Korean Ophthalmol Soc 2004; 45 (12): 1981-8.

Fernandes M, Sridhar MS, Sangwan VS, et al.Amniotic membrane transplantation for ocular

surface reconstruction. Cornea 2005; 24 (6): 643-53.

Sangwan VS, Burman S, Tejwani S, et al.Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol 2007;55 (4): 251-60.

Niknejad H, Peirovi H, Jorjani M, et al.Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater 2008;15: 88-99.

King AE, Paltoo A, Kelly RW, et al. Expression of natural antimicrobials by human placenta and fetal membranes. Placenta 2007; 28 (2-3): 161-9.

Ni J, Abrahamson M, Zhang M, et al. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family Z cystatins. J Biol Chem 1997; 272 (16): 10853-8.

Kamal JD, Pfaller MA, Rempe LE, et al.Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA 1991; 265 (18): 2364-8.

Raad I, Darouiche R, Hachem R, et al.Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995; 39 (11): 2397-400.

Alonso-Echanove J, Edwards JR, Richards MJ, et al. Effect of nurse staffing and antimicrobial- impregnated central venous catheters on the risk for bloodstream infections in intensive care units.Infect Control Hosp Epidemiol 2003; 24 (12):916-25.

Eveillard M, Mertl P, Tramier B, et al.Effectiveness of gentamicin-impregnated cement in the prevention of deep wound infection after primary total knee arthroplasty. Infect Control Hosp Epidemiol 2003; 24 (10): 778-80.

IssueVol 1 No 1-2 (2012) QRcode
SectionOriginal Articles
Pseudomonas aeruginosa Amnion Ciprofloxacin Keratitis Rabbits

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Soltan-Dallal MM, Nikkhahi F, Molaei S, Hosseini K, Kalafi Z, khoshzaban A, Rastegar-Lari A, Kheirkhah A, Sharifi-Yazdi MK. Effect of Amniotic Membrane Combined with Ciprofloxacin in Curing the Primary Stages of Pseudomonal Keratitis. J Med Bacteriol. 2015;1(1-2):31-37.